Presenilin mutations in Alzheimer's disease - PubMed (original) (raw)
Review
Presenilin mutations in Alzheimer's disease
M Cruts et al. Hum Mutat. 1998.
Abstract
The presenilins (PS-1 and PS-2) are 2 members of a novel family of genes encoding integral membrane proteins recently implicated in Alzheimer's disease (AD) pathology. To date, 43 mutations have been identified in PS-1 and 2 in PS-2 that lead to familial presenile AD (onset before age 65 years). The normal and pathological functions of the PS proteins (ps-1 and ps-2) are unknown, but their high degree of homology predicts similar biological activities. Homologies with ps from other species suggest that they may play a role in intracellular protein sorting and trafficking, in intercellular cell signaling, or in cell death. Since to date only missense mutations and in-frame deletions were identified, it is believed that mutated ps act through either a gain of (dys-)function or a dominant negative effect. In vivo and in vitro studies have linked PS mutations to amyloid deposition, an early pathological event in AD brains.
Similar articles
- [Presenilins as a marker of Alzheimer's disease].
Scheper W, van Gool WA. Scheper W, et al. Ned Tijdschr Geneeskd. 1998 May 30;142(22):1247-52. Ned Tijdschr Geneeskd. 1998. PMID: 9749296 Review. Dutch. - Presenilins and early-onset familial Alzheimer's disease.
Rohan de Silva HA, Patel AJ. Rohan de Silva HA, et al. Neuroreport. 1997 May 27;8(8):i-xii. Neuroreport. 1997. PMID: 9223053 Review. - Presenilins: multifunctional proteins involved in Alzheimer's disease pathology.
Checler F. Checler F. IUBMB Life. 1999 Jul;48(1):33-9. doi: 10.1080/713803480. IUBMB Life. 1999. PMID: 10791913 Review. - [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI. Rogaev EI. Genetika. 1999 Nov;35(11):1558-71. Genetika. 1999. PMID: 10624576 Review. Russian. - Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene.
Poorkaj P, Sharma V, Anderson L, Nemens E, Alonso ME, Orr H, White J, Heston L, Bird TD, Schellenberg GD. Poorkaj P, et al. Hum Mutat. 1998;11(3):216-21. doi: 10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.0.CO;2-F. Hum Mutat. 1998. PMID: 9521423
Cited by
- Cyclitols: From Basic Understanding to Their Association with Neurodegeneration.
Derkaczew M, Martyniuk P, Osowski A, Wojtkiewicz J. Derkaczew M, et al. Nutrients. 2023 Apr 23;15(9):2029. doi: 10.3390/nu15092029. Nutrients. 2023. PMID: 37432155 Free PMC article. Review. - Ultra-Early Screening of Cognitive Decline Due to Alzheimer's Pathology.
Wei P. Wei P. Biomedicines. 2023 May 11;11(5):1423. doi: 10.3390/biomedicines11051423. Biomedicines. 2023. PMID: 37239094 Free PMC article. Review. - Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments.
Gomes GN, Levine ZA. Gomes GN, et al. J Phys Chem B. 2021 Mar 4;125(8):1974-1996. doi: 10.1021/acs.jpcb.0c09193. Epub 2021 Jan 19. J Phys Chem B. 2021. PMID: 33464098 Free PMC article. Review. - Robust Sampling of Defective Pathways in Alzheimer's Disease. Implications in Drug Repositioning.
Fernández-Martínez JL, Álvarez-Machancoses Ó, de Andrés-Galiana EJ, Bea G, Kloczkowski A. Fernández-Martínez JL, et al. Int J Mol Sci. 2020 May 19;21(10):3594. doi: 10.3390/ijms21103594. Int J Mol Sci. 2020. PMID: 32438758 Free PMC article. - A Clinical Case of Patient Carrying Rare Pathological PSEN1 Gene Mutation (L424V) Demonstrates the Phenotypic Heterogenity of Early Onset Familial AD.
Stoychev KR, Stoimenova-Popova M, Chumpalova P, Ilieva L, Swamad M, Kamburova-Martinova Z. Stoychev KR, et al. Front Psychiatry. 2019 Dec 11;10:857. doi: 10.3389/fpsyt.2019.00857. eCollection 2019. Front Psychiatry. 2019. PMID: 31920735 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases